<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Real-Time Oncology Review; Draft Guidance for Industry; Availability</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Real-Time Oncology Review; Draft Guidance for Industry; Availability</h1>
    <p class="timestamp">Published: 2022-07-22 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The Food and Drug Administration (FDA or Agency) is announcing the availability of a draft guidance for industry entitled "Real-Time Oncology Review (RTOR)." The purpose of this guidance is to provide recommendations to applicants on the process for submission of selected new drug applications (NDAs) and biologics license applications (BLAs) with oncology indications for review under RTOR.</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, Food and Drug Administration</p>
    <p><strong>Document Number:</strong> 2022-15676</p>
    <p><strong>Publication Date:</strong> 2022-07-22</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2022/07/22/2022-15676/real-time-oncology-review-draft-guidance-for-industry-availability">https://www.federalregister.gov/documents/2022/07/22/2022-15676/real-time-oncology-review-draft-guidance-for-industry-availability</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2022-15676</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
